P30HD106451

The Indiana University-Ohio State University Maternal and Pediatric Precision in Therapeutics Data, Model, Knowledge, and Research Coordination Center (IU-OSU MPRINT DMKRCC) - Summary (Overall)

The Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub will serve as a national resource for multidisciplinary expertise and knowledge in maternal and pediatric therapeutics. The MPRINT Data, Model, Knowledge, and Research Coordination Center (DMKRCC) will support the MPRINT Centers of Excellence in Therapeutics (CET) and Steering Committee to coordinate and expand research relating to maternal and pediatric therapeutics.

The DMKRCC will serve as the administrative component of the MPRINT Hub, coordinate outreach and dissemination of MPRINT Hub activities, and will serve as a conduit between the MPRINT Hub and the broader scientific community. Additionally, the MPRINT DMKRCC will organize annual MPRINT meetings and educational activities, including webinars, to cultivate translational research in maternal and pediatric therapeutics.

The DMKRCC will identify, aggregate, and make available data, knowledge, and expertise in maternal and pediatric therapeutics to the wider research, drug development, and regulatory communities. Specifically, the DMKRCC will identify, evaluate, and collate pertinent data in a knowledge base that will be made available through a web portal; utilize and enhance pharmacometric modeling approaches such as physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD); support clinical trial design; and foster expertise in drug development and personalized therapy for maternal and pediatric populations.

The specific aims of this proposal will develop a cohesive organizational structure to support the research of the MPRINT Hub as a whole as well as the individual cores within the DMKRCC. We will develop infrastructure to facilitate data sharing and knowledge dissemination, and work with the CETs and Steering Committee to identify and address changing needs of the maternal and pediatric communities.

Trustees Of Indiana University

TO CONDUCT AND SUPPORT LABORATORY RESEARCH, CLINICAL TRIALS, AND STUDIES WITH PEOPLE THAT EXPLORE HEALTH PROCESSES. NICHD RESEARCHERS EXAMINE GROWTH AND DEVELOPMENT, BIOLOGIC AND REPRODUCTIVE FUNCTIONS, BEHAVIOR PATTERNS, AND POPULATION DYNAMICS TO PROTECT AND MAINTAIN THE HEALTH OF ALL PEOPLE. TO EXAMINE THE IMPACT OF DISABILITIES, DISEASES, AND DEFECTS ON THE LIVES OF INDIVIDUALS. WITH THIS INFORMATION, THE NICHD HOPES TO RESTORE, INCREASE, AND MAXIMIZE THE CAPABILITIES OF PEOPLE AFFECTED BY DISEASE AND INJURY. TO SPONSOR TRAINING PROGRAMS FOR SCIENTISTS, DOCTORS, AND RESEARCHERS TO ENSURE THAT NICHD RESEARCH CAN CONTINUE. BY TRAINING THESE PROFESSIONALS IN THE LATEST RESEARCH METHODS AND TECHNOLOGIES, THE NICHD WILL BE ABLE TO CONDUCT ITS RESEARCH AND MAKE HEALTH RESEARCH PROGRESS UNTIL ALL CHILDREN, ADULTS, FAMILIES, AND POPULATIONS ENJOY GOOD HEALTH. THE MISSION OF THE NICHD IS TO ENSURE THAT EVERY PERSON IS BORN HEALTHY AND WANTED, THAT WOMEN SUFFER NO HARMFUL EFFECTS FROM REPRODUCTIVE PROCESSES, AND THAT ALL CHILDREN HAVE THE CHANCE TO ACHIEVE THEIR FULL POTENTIAL FOR HEALTHY AND PRODUCTIVE LIVES, FREE FROM DISEASE OR DISABILITY, AND TO ENSURE THE HEALTH, PRODUCTIVITY, INDEPENDENCE, AND WELL-BEING OF ALL PEOPLE THROUGH OPTIMAL REHABILITATION.

93.865 - Child Health and Human Development Extramural Research

National Institute of Child Health and Human Development (NICHD) [HHS - NIH]

Indianapolis, Indiana 462025188 United States

Single Zip Code

Maternal and Pediatrics Precision in Therapeutics Hub (MPRINT) (P30 Clinical Trial Not Allowed) (RFA-HD-21-025)

Amendment Since initial award the total obligations have increased 483% from $2,999,998 to $17,481,052.